Description
Toxsta is a botulinum toxin type A formulation manufactured in South Korea, containing the neurotoxin complex stabilised with human serum albumin and sodium chloride in a lyophilised format. It is designed for aesthetic neuromodulation including glabellar frown lines, forehead rhytids, and periorbital crow's feet, with off-label use for neck bands, brow lifting, and facial contouring.
Indication
Designed for professional use in protocols addressing the appearance of facial expression lines, intended for application by trained practitioners within established aesthetic frameworks.
Packaging
Supplied in vials for professional aesthetic use, intended for trained practitioners.
Protocol
Reconstitute 100-unit vial with 2.5 mL preservative-free 0.9% saline (40 units/mL). Administer intramuscularly using a 30–32G needle; glabellar: 20–25 units across 5 sites; forehead: 10–20 units; lateral canthal lines: 6–12 units per side. Onset 2–4 days; maximum effect at 7–14 days. Repeat every 3–4 months.
